Cordlife Group (SG:P8A) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Cordlife Group Limited has been directed by the Ministry of Health to halt its cord blood and human tissue services due to non-compliance with healthcare regulations. The company is actively working on rectification measures, establishing an oversight committee and a Medical and Technical Advisory Board to address the issues. They have also partnered with Shandong Qilu Stemcell Engineering to assist in improving their operations during this period.
For further insights into SG:P8A stock, check out TipRanks’ Stock Analysis page.
